nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—SLC22A1—hematologic cancer	0.259	1	CbGaD
Diphenhydramine—CYP2C18—Ifosfamide—hematologic cancer	0.0317	0.0587	CbGbCtD
Diphenhydramine—SLC22A2—Daunorubicin—hematologic cancer	0.0241	0.0446	CbGbCtD
Diphenhydramine—SLC22A2—Cytarabine—hematologic cancer	0.0212	0.0394	CbGbCtD
Diphenhydramine—SLC22A2—Cladribine—hematologic cancer	0.0201	0.0372	CbGbCtD
Diphenhydramine—SLC22A1—Cytarabine—hematologic cancer	0.0184	0.0342	CbGbCtD
Diphenhydramine—SLC22A2—Imatinib—hematologic cancer	0.0184	0.0342	CbGbCtD
Diphenhydramine—CYP1A2—Anagrelide—hematologic cancer	0.018	0.0334	CbGbCtD
Diphenhydramine—CYP2B6—Thiotepa—hematologic cancer	0.0177	0.0327	CbGbCtD
Diphenhydramine—SLC22A1—Cladribine—hematologic cancer	0.0174	0.0323	CbGbCtD
Diphenhydramine—PTGS1—Bortezomib—hematologic cancer	0.0171	0.0318	CbGbCtD
Diphenhydramine—SLC22A1—Imatinib—hematologic cancer	0.016	0.0297	CbGbCtD
Diphenhydramine—PTGS1—Thalidomide—hematologic cancer	0.0149	0.0277	CbGbCtD
Diphenhydramine—PTGS1—Ifosfamide—hematologic cancer	0.0132	0.0244	CbGbCtD
Diphenhydramine—PTGS1—Imatinib—hematologic cancer	0.0126	0.0233	CbGbCtD
Diphenhydramine—CYP2C9—Bexarotene—hematologic cancer	0.0113	0.0209	CbGbCtD
Diphenhydramine—SLC22A2—Vinblastine—hematologic cancer	0.0102	0.019	CbGbCtD
Diphenhydramine—CYP2B6—Ifosfamide—hematologic cancer	0.01	0.0186	CbGbCtD
Diphenhydramine—CYP2D6—Lomustine—hematologic cancer	0.00957	0.0177	CbGbCtD
Diphenhydramine—CYP1A2—Carmustine—hematologic cancer	0.00947	0.0176	CbGbCtD
Diphenhydramine—SLC22A2—Cisplatin—hematologic cancer	0.00939	0.0174	CbGbCtD
Diphenhydramine—CYP2C9—Idarubicin—hematologic cancer	0.00933	0.0173	CbGbCtD
Diphenhydramine—CYP2B6—Nilotinib—hematologic cancer	0.0087	0.0161	CbGbCtD
Diphenhydramine—CYP2D6—Idarubicin—hematologic cancer	0.00853	0.0158	CbGbCtD
Diphenhydramine—CYP2C19—Bortezomib—hematologic cancer	0.0083	0.0154	CbGbCtD
Diphenhydramine—CYP1A2—Methoxsalen—hematologic cancer	0.00805	0.0149	CbGbCtD
Diphenhydramine—CYP1A2—Bortezomib—hematologic cancer	0.00766	0.0142	CbGbCtD
Diphenhydramine—CYP1A2—Daunorubicin—hematologic cancer	0.00733	0.0136	CbGbCtD
Diphenhydramine—CYP2D6—Hydroxyurea—hematologic cancer	0.00725	0.0135	CbGbCtD
Diphenhydramine—CYP2C19—Thalidomide—hematologic cancer	0.00723	0.0134	CbGbCtD
Diphenhydramine—CYP1A2—Alitretinoin—hematologic cancer	0.00718	0.0133	CbGbCtD
Diphenhydramine—CYP2C9—Bortezomib—hematologic cancer	0.0069	0.0128	CbGbCtD
Diphenhydramine—CYP2C19—Teniposide—hematologic cancer	0.0069	0.0128	CbGbCtD
Diphenhydramine—CYP1A2—Thalidomide—hematologic cancer	0.00667	0.0124	CbGbCtD
Diphenhydramine—CYP2C19—Ifosfamide—hematologic cancer	0.00637	0.0118	CbGbCtD
Diphenhydramine—CYP2D6—Bortezomib—hematologic cancer	0.00631	0.0117	CbGbCtD
Diphenhydramine—PTGS1—Etoposide—hematologic cancer	0.00628	0.0117	CbGbCtD
Diphenhydramine—CYP2C19—Imatinib—hematologic cancer	0.00608	0.0113	CbGbCtD
Diphenhydramine—CYP2C9—Thalidomide—hematologic cancer	0.00601	0.0111	CbGbCtD
Diphenhydramine—CYP2B6—Irinotecan—hematologic cancer	0.00598	0.0111	CbGbCtD
Diphenhydramine—CYP1A2—Dacarbazine—hematologic cancer	0.00574	0.0106	CbGbCtD
Diphenhydramine—CYP2C9—Teniposide—hematologic cancer	0.00574	0.0106	CbGbCtD
Diphenhydramine—CYP1A2—Imatinib—hematologic cancer	0.00561	0.0104	CbGbCtD
Diphenhydramine—CYP2C9—Ifosfamide—hematologic cancer	0.00529	0.00981	CbGbCtD
Diphenhydramine—CYP2C9—Imatinib—hematologic cancer	0.00506	0.00937	CbGbCtD
Diphenhydramine—CYP2B6—Cisplatin—hematologic cancer	0.00487	0.00904	CbGbCtD
Diphenhydramine—CYP2D6—Imatinib—hematologic cancer	0.00462	0.00857	CbGbCtD
Diphenhydramine—CYP2C9—Nilotinib—hematologic cancer	0.0046	0.00852	CbGbCtD
Diphenhydramine—CYP1A2—Dasatinib—hematologic cancer	0.00451	0.00836	CbGbCtD
Diphenhydramine—CYP2D6—Nilotinib—hematologic cancer	0.0042	0.00779	CbGbCtD
Diphenhydramine—CYP2D6—Vinorelbine—hematologic cancer	0.00417	0.00773	CbGbCtD
Diphenhydramine—CYP2C19—Prednisone—hematologic cancer	0.00401	0.00743	CbGbCtD
Diphenhydramine—CYP2B6—Dexamethasone—hematologic cancer	0.00394	0.0073	CbGbCtD
Diphenhydramine—CYP2B6—Doxorubicin—hematologic cancer	0.00327	0.00606	CbGbCtD
Diphenhydramine—CYP1A2—Etoposide—hematologic cancer	0.00281	0.00521	CbGbCtD
Diphenhydramine—CYP2C9—Cisplatin—hematologic cancer	0.00257	0.00477	CbGbCtD
Diphenhydramine—CYP2D6—Vinblastine—hematologic cancer	0.00257	0.00476	CbGbCtD
Diphenhydramine—CYP2C19—Dexamethasone—hematologic cancer	0.0025	0.00464	CbGbCtD
Diphenhydramine—CYP2C9—Dexamethasone—hematologic cancer	0.00208	0.00386	CbGbCtD
Diphenhydramine—CYP2D6—Dexamethasone—hematologic cancer	0.0019	0.00353	CbGbCtD
Diphenhydramine—CYP2D6—Doxorubicin—hematologic cancer	0.00158	0.00293	CbGbCtD
Diphenhydramine—Toremifene—ESR1—hematologic cancer	0.000133	0.107	CrCbGaD
Diphenhydramine—Chlorphenamine—SLC22A1—hematologic cancer	0.000118	0.0942	CrCbGaD
Diphenhydramine—Clomifene—ESR1—hematologic cancer	0.000115	0.0922	CrCbGaD
Diphenhydramine—Phenoxybenzamine—SLC22A1—hematologic cancer	9.52e-05	0.0763	CrCbGaD
Diphenhydramine—Reboxetine—ABCB1—hematologic cancer	7.14e-05	0.0571	CrCbGaD
Diphenhydramine—Imipramine—SLC22A1—hematologic cancer	6.03e-05	0.0483	CrCbGaD
Diphenhydramine—Neuropathy peripheral—Epirubicin—hematologic cancer	5.86e-05	0.000388	CcSEcCtD
Diphenhydramine—Vomiting—Thalidomide—hematologic cancer	5.82e-05	0.000386	CcSEcCtD
Diphenhydramine—Dizziness—Carmustine—hematologic cancer	5.81e-05	0.000386	CcSEcCtD
Diphenhydramine—Constipation—Etoposide—hematologic cancer	5.81e-05	0.000386	CcSEcCtD
Diphenhydramine—Dysuria—Doxorubicin—hematologic cancer	5.8e-05	0.000384	CcSEcCtD
Diphenhydramine—Rash—Thalidomide—hematologic cancer	5.77e-05	0.000383	CcSEcCtD
Diphenhydramine—Dermatitis—Thalidomide—hematologic cancer	5.77e-05	0.000382	CcSEcCtD
Diphenhydramine—Dizziness—Alitretinoin—hematologic cancer	5.76e-05	0.000382	CcSEcCtD
Diphenhydramine—Diarrhoea—Vincristine—hematologic cancer	5.74e-05	0.000381	CcSEcCtD
Diphenhydramine—Headache—Thalidomide—hematologic cancer	5.74e-05	0.00038	CcSEcCtD
Diphenhydramine—Pollakiuria—Doxorubicin—hematologic cancer	5.73e-05	0.00038	CcSEcCtD
Diphenhydramine—Asthenia—Gemcitabine—hematologic cancer	5.71e-05	0.000379	CcSEcCtD
Diphenhydramine—Dizziness—Ifosfamide—hematologic cancer	5.69e-05	0.000377	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Doxorubicin—hematologic cancer	5.66e-05	0.000375	CcSEcCtD
Diphenhydramine—Toremifene—ABCB1—hematologic cancer	5.66e-05	0.0453	CrCbGaD
Diphenhydramine—Vision blurred—Prednisone—hematologic cancer	5.63e-05	0.000373	CcSEcCtD
Diphenhydramine—Nausea—Thiotepa—hematologic cancer	5.62e-05	0.000373	CcSEcCtD
Diphenhydramine—Feeling abnormal—Etoposide—hematologic cancer	5.6e-05	0.000372	CcSEcCtD
Diphenhydramine—Diarrhoea—Irinotecan—hematologic cancer	5.59e-05	0.000371	CcSEcCtD
Diphenhydramine—Diarrhoea—Mitoxantrone—hematologic cancer	5.59e-05	0.000371	CcSEcCtD
Diphenhydramine—Vomiting—Carmustine—hematologic cancer	5.59e-05	0.000371	CcSEcCtD
Diphenhydramine—Fenoprofen—ALB—hematologic cancer	5.59e-05	0.0448	CrCbGaD
Diphenhydramine—Insomnia—Triamcinolone—hematologic cancer	5.58e-05	0.00037	CcSEcCtD
Diphenhydramine—Agranulocytosis—Epirubicin—hematologic cancer	5.58e-05	0.00037	CcSEcCtD
Diphenhydramine—Dizziness—Vincristine—hematologic cancer	5.55e-05	0.000368	CcSEcCtD
Diphenhydramine—Rash—Carmustine—hematologic cancer	5.54e-05	0.000368	CcSEcCtD
Diphenhydramine—Dermatitis—Carmustine—hematologic cancer	5.54e-05	0.000367	CcSEcCtD
Diphenhydramine—Vomiting—Alitretinoin—hematologic cancer	5.54e-05	0.000367	CcSEcCtD
Diphenhydramine—Paraesthesia—Triamcinolone—hematologic cancer	5.54e-05	0.000367	CcSEcCtD
Diphenhydramine—Drowsiness—Doxorubicin—hematologic cancer	5.53e-05	0.000367	CcSEcCtD
Diphenhydramine—Feeling abnormal—Prednisolone—hematologic cancer	5.53e-05	0.000366	CcSEcCtD
Diphenhydramine—Headache—Carmustine—hematologic cancer	5.51e-05	0.000365	CcSEcCtD
Diphenhydramine—Rash—Alitretinoin—hematologic cancer	5.49e-05	0.000364	CcSEcCtD
Diphenhydramine—Agitation—Prednisone—hematologic cancer	5.49e-05	0.000364	CcSEcCtD
Diphenhydramine—Dermatitis—Alitretinoin—hematologic cancer	5.49e-05	0.000364	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Betamethasone—hematologic cancer	5.48e-05	0.000363	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Dexamethasone—hematologic cancer	5.48e-05	0.000363	CcSEcCtD
Diphenhydramine—Vomiting—Ifosfamide—hematologic cancer	5.47e-05	0.000363	CcSEcCtD
Diphenhydramine—Tachycardia—Betamethasone—hematologic cancer	5.46e-05	0.000362	CcSEcCtD
Diphenhydramine—Tachycardia—Dexamethasone—hematologic cancer	5.46e-05	0.000362	CcSEcCtD
Diphenhydramine—Headache—Alitretinoin—hematologic cancer	5.46e-05	0.000362	CcSEcCtD
Diphenhydramine—Diarrhoea—Gemcitabine—hematologic cancer	5.45e-05	0.000361	CcSEcCtD
Diphenhydramine—Nausea—Thalidomide—hematologic cancer	5.44e-05	0.000361	CcSEcCtD
Diphenhydramine—Tamoxifen—ABCG2—hematologic cancer	5.43e-05	0.0435	CrCbGaD
Diphenhydramine—Dyspepsia—Triamcinolone—hematologic cancer	5.43e-05	0.00036	CcSEcCtD
Diphenhydramine—Rash—Ifosfamide—hematologic cancer	5.43e-05	0.00036	CcSEcCtD
Diphenhydramine—Dermatitis—Ifosfamide—hematologic cancer	5.42e-05	0.00036	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Doxorubicin—hematologic cancer	5.42e-05	0.000359	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Dexamethasone—hematologic cancer	5.41e-05	0.000359	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Betamethasone—hematologic cancer	5.41e-05	0.000359	CcSEcCtD
Diphenhydramine—Dizziness—Irinotecan—hematologic cancer	5.41e-05	0.000358	CcSEcCtD
Diphenhydramine—Urticaria—Etoposide—hematologic cancer	5.4e-05	0.000358	CcSEcCtD
Diphenhydramine—Vertigo—Prednisone—hematologic cancer	5.36e-05	0.000356	CcSEcCtD
Diphenhydramine—Tinnitus—Methotrexate—hematologic cancer	5.34e-05	0.000354	CcSEcCtD
Diphenhydramine—Vomiting—Vincristine—hematologic cancer	5.34e-05	0.000354	CcSEcCtD
Diphenhydramine—Anorexia—Dexamethasone—hematologic cancer	5.33e-05	0.000354	CcSEcCtD
Diphenhydramine—Anorexia—Betamethasone—hematologic cancer	5.33e-05	0.000354	CcSEcCtD
Diphenhydramine—Urticaria—Prednisolone—hematologic cancer	5.33e-05	0.000353	CcSEcCtD
Diphenhydramine—Asthenia—Cisplatin—hematologic cancer	5.33e-05	0.000353	CcSEcCtD
Diphenhydramine—Tamoxifen—ESR1—hematologic cancer	5.32e-05	0.0426	CrCbGaD
Diphenhydramine—Fatigue—Triamcinolone—hematologic cancer	5.32e-05	0.000353	CcSEcCtD
Diphenhydramine—Rash—Vincristine—hematologic cancer	5.29e-05	0.000351	CcSEcCtD
Diphenhydramine—Dermatitis—Vincristine—hematologic cancer	5.29e-05	0.000351	CcSEcCtD
Diphenhydramine—Headache—Vincristine—hematologic cancer	5.26e-05	0.000349	CcSEcCtD
Diphenhydramine—Hypotension—Dexamethasone—hematologic cancer	5.23e-05	0.000347	CcSEcCtD
Diphenhydramine—Hypotension—Betamethasone—hematologic cancer	5.23e-05	0.000347	CcSEcCtD
Diphenhydramine—Nausea—Carmustine—hematologic cancer	5.22e-05	0.000346	CcSEcCtD
Diphenhydramine—Vomiting—Irinotecan—hematologic cancer	5.2e-05	0.000345	CcSEcCtD
Diphenhydramine—Vomiting—Mitoxantrone—hematologic cancer	5.2e-05	0.000345	CcSEcCtD
Diphenhydramine—Nausea—Alitretinoin—hematologic cancer	5.17e-05	0.000343	CcSEcCtD
Diphenhydramine—Convulsion—Prednisone—hematologic cancer	5.17e-05	0.000343	CcSEcCtD
Diphenhydramine—Agranulocytosis—Doxorubicin—hematologic cancer	5.16e-05	0.000342	CcSEcCtD
Diphenhydramine—Rash—Mitoxantrone—hematologic cancer	5.15e-05	0.000342	CcSEcCtD
Diphenhydramine—Rash—Irinotecan—hematologic cancer	5.15e-05	0.000342	CcSEcCtD
Diphenhydramine—Dermatitis—Mitoxantrone—hematologic cancer	5.15e-05	0.000341	CcSEcCtD
Diphenhydramine—Dermatitis—Irinotecan—hematologic cancer	5.15e-05	0.000341	CcSEcCtD
Diphenhydramine—Chills—Methotrexate—hematologic cancer	5.14e-05	0.000341	CcSEcCtD
Diphenhydramine—Headache—Mitoxantrone—hematologic cancer	5.12e-05	0.00034	CcSEcCtD
Diphenhydramine—Headache—Irinotecan—hematologic cancer	5.12e-05	0.00034	CcSEcCtD
Diphenhydramine—Nausea—Ifosfamide—hematologic cancer	5.11e-05	0.000339	CcSEcCtD
Diphenhydramine—Feeling abnormal—Triamcinolone—hematologic cancer	5.08e-05	0.000337	CcSEcCtD
Diphenhydramine—Diarrhoea—Cisplatin—hematologic cancer	5.08e-05	0.000337	CcSEcCtD
Diphenhydramine—Vomiting—Gemcitabine—hematologic cancer	5.06e-05	0.000336	CcSEcCtD
Diphenhydramine—Insomnia—Betamethasone—hematologic cancer	5.06e-05	0.000336	CcSEcCtD
Diphenhydramine—Insomnia—Dexamethasone—hematologic cancer	5.06e-05	0.000336	CcSEcCtD
Diphenhydramine—Paraesthesia—Betamethasone—hematologic cancer	5.02e-05	0.000333	CcSEcCtD
Diphenhydramine—Paraesthesia—Dexamethasone—hematologic cancer	5.02e-05	0.000333	CcSEcCtD
Diphenhydramine—Rash—Gemcitabine—hematologic cancer	5.02e-05	0.000333	CcSEcCtD
Diphenhydramine—Dermatitis—Gemcitabine—hematologic cancer	5.02e-05	0.000333	CcSEcCtD
Diphenhydramine—Tinnitus—Epirubicin—hematologic cancer	5e-05	0.000332	CcSEcCtD
Diphenhydramine—Headache—Gemcitabine—hematologic cancer	4.99e-05	0.000331	CcSEcCtD
Diphenhydramine—Nausea—Vincristine—hematologic cancer	4.99e-05	0.000331	CcSEcCtD
Diphenhydramine—Dyspepsia—Betamethasone—hematologic cancer	4.93e-05	0.000327	CcSEcCtD
Diphenhydramine—Dyspepsia—Dexamethasone—hematologic cancer	4.93e-05	0.000327	CcSEcCtD
Diphenhydramine—Urticaria—Triamcinolone—hematologic cancer	4.9e-05	0.000325	CcSEcCtD
Diphenhydramine—Clomifene—ABCB1—hematologic cancer	4.89e-05	0.0392	CrCbGaD
Diphenhydramine—Asthenia—Etoposide—hematologic cancer	4.88e-05	0.000323	CcSEcCtD
Diphenhydramine—Decreased appetite—Betamethasone—hematologic cancer	4.86e-05	0.000323	CcSEcCtD
Diphenhydramine—Decreased appetite—Dexamethasone—hematologic cancer	4.86e-05	0.000323	CcSEcCtD
Diphenhydramine—Nausea—Mitoxantrone—hematologic cancer	4.86e-05	0.000322	CcSEcCtD
Diphenhydramine—Nausea—Irinotecan—hematologic cancer	4.86e-05	0.000322	CcSEcCtD
Diphenhydramine—Fatigue—Betamethasone—hematologic cancer	4.82e-05	0.00032	CcSEcCtD
Diphenhydramine—Fatigue—Dexamethasone—hematologic cancer	4.82e-05	0.00032	CcSEcCtD
Diphenhydramine—Phenprocoumon—ALB—hematologic cancer	4.82e-05	0.0386	CrCbGaD
Diphenhydramine—Chills—Epirubicin—hematologic cancer	4.81e-05	0.000319	CcSEcCtD
Diphenhydramine—Tachycardia—Prednisone—hematologic cancer	4.76e-05	0.000315	CcSEcCtD
Diphenhydramine—Nausea—Gemcitabine—hematologic cancer	4.73e-05	0.000314	CcSEcCtD
Diphenhydramine—Vomiting—Cisplatin—hematologic cancer	4.72e-05	0.000313	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Prednisone—hematologic cancer	4.71e-05	0.000312	CcSEcCtD
Diphenhydramine—Vision blurred—Methotrexate—hematologic cancer	4.7e-05	0.000312	CcSEcCtD
Diphenhydramine—Rash—Cisplatin—hematologic cancer	4.68e-05	0.00031	CcSEcCtD
Diphenhydramine—Dermatitis—Cisplatin—hematologic cancer	4.68e-05	0.00031	CcSEcCtD
Diphenhydramine—Diarrhoea—Etoposide—hematologic cancer	4.65e-05	0.000308	CcSEcCtD
Diphenhydramine—Anorexia—Prednisone—hematologic cancer	4.65e-05	0.000308	CcSEcCtD
Diphenhydramine—Tinnitus—Doxorubicin—hematologic cancer	4.63e-05	0.000307	CcSEcCtD
Diphenhydramine—Feeling abnormal—Betamethasone—hematologic cancer	4.61e-05	0.000306	CcSEcCtD
Diphenhydramine—Feeling abnormal—Dexamethasone—hematologic cancer	4.61e-05	0.000306	CcSEcCtD
Diphenhydramine—Tension—Epirubicin—hematologic cancer	4.58e-05	0.000304	CcSEcCtD
Diphenhydramine—Nervousness—Epirubicin—hematologic cancer	4.54e-05	0.000301	CcSEcCtD
Diphenhydramine—Dizziness—Etoposide—hematologic cancer	4.5e-05	0.000298	CcSEcCtD
Diphenhydramine—Vertigo—Methotrexate—hematologic cancer	4.48e-05	0.000297	CcSEcCtD
Diphenhydramine—Chills—Doxorubicin—hematologic cancer	4.45e-05	0.000295	CcSEcCtD
Diphenhydramine—Urticaria—Dexamethasone—hematologic cancer	4.45e-05	0.000295	CcSEcCtD
Diphenhydramine—Urticaria—Betamethasone—hematologic cancer	4.45e-05	0.000295	CcSEcCtD
Diphenhydramine—Dizziness—Prednisolone—hematologic cancer	4.43e-05	0.000294	CcSEcCtD
Diphenhydramine—Asthenia—Triamcinolone—hematologic cancer	4.42e-05	0.000293	CcSEcCtD
Diphenhydramine—Nausea—Cisplatin—hematologic cancer	4.41e-05	0.000292	CcSEcCtD
Diphenhydramine—Insomnia—Prednisone—hematologic cancer	4.41e-05	0.000292	CcSEcCtD
Diphenhydramine—Vision blurred—Epirubicin—hematologic cancer	4.4e-05	0.000292	CcSEcCtD
Diphenhydramine—Paraesthesia—Prednisone—hematologic cancer	4.38e-05	0.00029	CcSEcCtD
Diphenhydramine—CYP2C19—hematopoietic system—hematologic cancer	4.33e-05	0.063	CbGeAlD
Diphenhydramine—Convulsion—Methotrexate—hematologic cancer	4.32e-05	0.000287	CcSEcCtD
Diphenhydramine—Vomiting—Etoposide—hematologic cancer	4.32e-05	0.000287	CcSEcCtD
Diphenhydramine—Agitation—Epirubicin—hematologic cancer	4.29e-05	0.000285	CcSEcCtD
Diphenhydramine—Dyspepsia—Prednisone—hematologic cancer	4.29e-05	0.000284	CcSEcCtD
Diphenhydramine—Rash—Etoposide—hematologic cancer	4.29e-05	0.000284	CcSEcCtD
Diphenhydramine—Dermatitis—Etoposide—hematologic cancer	4.28e-05	0.000284	CcSEcCtD
Diphenhydramine—Warfarin—ALB—hematologic cancer	4.27e-05	0.0342	CrCbGaD
Diphenhydramine—Headache—Etoposide—hematologic cancer	4.26e-05	0.000282	CcSEcCtD
Diphenhydramine—Tension—Doxorubicin—hematologic cancer	4.24e-05	0.000281	CcSEcCtD
Diphenhydramine—Decreased appetite—Prednisone—hematologic cancer	4.24e-05	0.000281	CcSEcCtD
Diphenhydramine—Rash—Prednisolone—hematologic cancer	4.23e-05	0.00028	CcSEcCtD
Diphenhydramine—Dermatitis—Prednisolone—hematologic cancer	4.22e-05	0.00028	CcSEcCtD
Diphenhydramine—Fatigue—Prednisone—hematologic cancer	4.2e-05	0.000279	CcSEcCtD
Diphenhydramine—Headache—Prednisolone—hematologic cancer	4.2e-05	0.000279	CcSEcCtD
Diphenhydramine—Nervousness—Doxorubicin—hematologic cancer	4.2e-05	0.000278	CcSEcCtD
Diphenhydramine—Vertigo—Epirubicin—hematologic cancer	4.2e-05	0.000278	CcSEcCtD
Diphenhydramine—Constipation—Prednisone—hematologic cancer	4.17e-05	0.000276	CcSEcCtD
Diphenhydramine—Palpitations—Epirubicin—hematologic cancer	4.13e-05	0.000274	CcSEcCtD
Diphenhydramine—Confusional state—Methotrexate—hematologic cancer	4.11e-05	0.000272	CcSEcCtD
Diphenhydramine—Dizziness—Triamcinolone—hematologic cancer	4.08e-05	0.00027	CcSEcCtD
Diphenhydramine—Vision blurred—Doxorubicin—hematologic cancer	4.07e-05	0.00027	CcSEcCtD
Diphenhydramine—Convulsion—Epirubicin—hematologic cancer	4.05e-05	0.000268	CcSEcCtD
Diphenhydramine—Nausea—Etoposide—hematologic cancer	4.04e-05	0.000268	CcSEcCtD
Diphenhydramine—Feeling abnormal—Prednisone—hematologic cancer	4.02e-05	0.000266	CcSEcCtD
Diphenhydramine—Asthenia—Betamethasone—hematologic cancer	4.01e-05	0.000266	CcSEcCtD
Diphenhydramine—Asthenia—Dexamethasone—hematologic cancer	4.01e-05	0.000266	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Methotrexate—hematologic cancer	3.99e-05	0.000264	CcSEcCtD
Diphenhydramine—Nausea—Prednisolone—hematologic cancer	3.98e-05	0.000264	CcSEcCtD
Diphenhydramine—Agitation—Doxorubicin—hematologic cancer	3.97e-05	0.000263	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Methotrexate—hematologic cancer	3.94e-05	0.000261	CcSEcCtD
Diphenhydramine—Vomiting—Triamcinolone—hematologic cancer	3.92e-05	0.00026	CcSEcCtD
Diphenhydramine—Rash—Triamcinolone—hematologic cancer	3.89e-05	0.000258	CcSEcCtD
Diphenhydramine—Dry mouth—Epirubicin—hematologic cancer	3.89e-05	0.000258	CcSEcCtD
Diphenhydramine—Dermatitis—Triamcinolone—hematologic cancer	3.89e-05	0.000258	CcSEcCtD
Diphenhydramine—Vertigo—Doxorubicin—hematologic cancer	3.88e-05	0.000257	CcSEcCtD
Diphenhydramine—Anorexia—Methotrexate—hematologic cancer	3.88e-05	0.000257	CcSEcCtD
Diphenhydramine—Urticaria—Prednisone—hematologic cancer	3.87e-05	0.000257	CcSEcCtD
Diphenhydramine—Headache—Triamcinolone—hematologic cancer	3.86e-05	0.000256	CcSEcCtD
Diphenhydramine—Confusional state—Epirubicin—hematologic cancer	3.84e-05	0.000255	CcSEcCtD
Diphenhydramine—Diarrhoea—Betamethasone—hematologic cancer	3.83e-05	0.000254	CcSEcCtD
Diphenhydramine—Diarrhoea—Dexamethasone—hematologic cancer	3.83e-05	0.000254	CcSEcCtD
Diphenhydramine—Palpitations—Doxorubicin—hematologic cancer	3.82e-05	0.000253	CcSEcCtD
Diphenhydramine—Hypotension—Methotrexate—hematologic cancer	3.81e-05	0.000252	CcSEcCtD
Diphenhydramine—Convulsion—Doxorubicin—hematologic cancer	3.74e-05	0.000248	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Epirubicin—hematologic cancer	3.73e-05	0.000247	CcSEcCtD
Diphenhydramine—SLC22A1—blood—hematologic cancer	3.72e-05	0.0541	CbGeAlD
Diphenhydramine—Tachycardia—Epirubicin—hematologic cancer	3.72e-05	0.000247	CcSEcCtD
Diphenhydramine—Dizziness—Betamethasone—hematologic cancer	3.7e-05	0.000245	CcSEcCtD
Diphenhydramine—Dizziness—Dexamethasone—hematologic cancer	3.7e-05	0.000245	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Epirubicin—hematologic cancer	3.68e-05	0.000244	CcSEcCtD
Diphenhydramine—Insomnia—Methotrexate—hematologic cancer	3.68e-05	0.000244	CcSEcCtD
Diphenhydramine—Nausea—Triamcinolone—hematologic cancer	3.66e-05	0.000243	CcSEcCtD
Diphenhydramine—Paraesthesia—Methotrexate—hematologic cancer	3.66e-05	0.000242	CcSEcCtD
Diphenhydramine—Anorexia—Epirubicin—hematologic cancer	3.63e-05	0.000241	CcSEcCtD
Diphenhydramine—Somnolence—Methotrexate—hematologic cancer	3.62e-05	0.00024	CcSEcCtD
Diphenhydramine—Dry mouth—Doxorubicin—hematologic cancer	3.6e-05	0.000239	CcSEcCtD
Diphenhydramine—Dyspepsia—Methotrexate—hematologic cancer	3.59e-05	0.000238	CcSEcCtD
Diphenhydramine—Hypotension—Epirubicin—hematologic cancer	3.56e-05	0.000236	CcSEcCtD
Diphenhydramine—Vomiting—Dexamethasone—hematologic cancer	3.56e-05	0.000236	CcSEcCtD
Diphenhydramine—Vomiting—Betamethasone—hematologic cancer	3.56e-05	0.000236	CcSEcCtD
Diphenhydramine—Confusional state—Doxorubicin—hematologic cancer	3.56e-05	0.000236	CcSEcCtD
Diphenhydramine—Bepridil—ABCB1—hematologic cancer	3.55e-05	0.0285	CrCbGaD
Diphenhydramine—Decreased appetite—Methotrexate—hematologic cancer	3.54e-05	0.000235	CcSEcCtD
Diphenhydramine—CYP1A2—hematopoietic system—hematologic cancer	3.54e-05	0.0515	CbGeAlD
Diphenhydramine—Rash—Betamethasone—hematologic cancer	3.53e-05	0.000234	CcSEcCtD
Diphenhydramine—Rash—Dexamethasone—hematologic cancer	3.53e-05	0.000234	CcSEcCtD
Diphenhydramine—Dermatitis—Dexamethasone—hematologic cancer	3.53e-05	0.000234	CcSEcCtD
Diphenhydramine—Dermatitis—Betamethasone—hematologic cancer	3.53e-05	0.000234	CcSEcCtD
Diphenhydramine—Fatigue—Methotrexate—hematologic cancer	3.51e-05	0.000233	CcSEcCtD
Diphenhydramine—Headache—Betamethasone—hematologic cancer	3.51e-05	0.000232	CcSEcCtD
Diphenhydramine—Headache—Dexamethasone—hematologic cancer	3.51e-05	0.000232	CcSEcCtD
Diphenhydramine—Asthenia—Prednisone—hematologic cancer	3.5e-05	0.000232	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Doxorubicin—hematologic cancer	3.45e-05	0.000229	CcSEcCtD
Diphenhydramine—Insomnia—Epirubicin—hematologic cancer	3.45e-05	0.000229	CcSEcCtD
Diphenhydramine—Tachycardia—Doxorubicin—hematologic cancer	3.44e-05	0.000228	CcSEcCtD
Diphenhydramine—Paraesthesia—Epirubicin—hematologic cancer	3.42e-05	0.000227	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Doxorubicin—hematologic cancer	3.41e-05	0.000226	CcSEcCtD
Diphenhydramine—CYP2B6—hematopoietic system—hematologic cancer	3.39e-05	0.0493	CbGeAlD
Diphenhydramine—Somnolence—Epirubicin—hematologic cancer	3.39e-05	0.000225	CcSEcCtD
Diphenhydramine—Anorexia—Doxorubicin—hematologic cancer	3.36e-05	0.000223	CcSEcCtD
Diphenhydramine—CYP2C9—hematopoietic system—hematologic cancer	3.36e-05	0.0488	CbGeAlD
Diphenhydramine—Feeling abnormal—Methotrexate—hematologic cancer	3.36e-05	0.000223	CcSEcCtD
Diphenhydramine—Dyspepsia—Epirubicin—hematologic cancer	3.36e-05	0.000222	CcSEcCtD
Diphenhydramine—Diarrhoea—Prednisone—hematologic cancer	3.33e-05	0.000221	CcSEcCtD
Diphenhydramine—Nausea—Dexamethasone—hematologic cancer	3.32e-05	0.00022	CcSEcCtD
Diphenhydramine—Nausea—Betamethasone—hematologic cancer	3.32e-05	0.00022	CcSEcCtD
Diphenhydramine—Decreased appetite—Epirubicin—hematologic cancer	3.31e-05	0.00022	CcSEcCtD
Diphenhydramine—HRH1—hematopoietic system—hematologic cancer	3.31e-05	0.0482	CbGeAlD
Diphenhydramine—Hypotension—Doxorubicin—hematologic cancer	3.3e-05	0.000218	CcSEcCtD
Diphenhydramine—Fatigue—Epirubicin—hematologic cancer	3.29e-05	0.000218	CcSEcCtD
Diphenhydramine—Fentanyl—ABCB1—hematologic cancer	3.27e-05	0.0262	CrCbGaD
Diphenhydramine—Constipation—Epirubicin—hematologic cancer	3.26e-05	0.000216	CcSEcCtD
Diphenhydramine—Urticaria—Methotrexate—hematologic cancer	3.24e-05	0.000215	CcSEcCtD
Diphenhydramine—Dizziness—Prednisone—hematologic cancer	3.22e-05	0.000214	CcSEcCtD
Diphenhydramine—Insomnia—Doxorubicin—hematologic cancer	3.19e-05	0.000211	CcSEcCtD
Diphenhydramine—Paraesthesia—Doxorubicin—hematologic cancer	3.17e-05	0.00021	CcSEcCtD
Diphenhydramine—Feeling abnormal—Epirubicin—hematologic cancer	3.14e-05	0.000208	CcSEcCtD
Diphenhydramine—Somnolence—Doxorubicin—hematologic cancer	3.14e-05	0.000208	CcSEcCtD
Diphenhydramine—Phenytoin—ALB—hematologic cancer	3.11e-05	0.0249	CrCbGaD
Diphenhydramine—Dyspepsia—Doxorubicin—hematologic cancer	3.1e-05	0.000206	CcSEcCtD
Diphenhydramine—Vomiting—Prednisone—hematologic cancer	3.1e-05	0.000205	CcSEcCtD
Diphenhydramine—Rash—Prednisone—hematologic cancer	3.07e-05	0.000204	CcSEcCtD
Diphenhydramine—Dermatitis—Prednisone—hematologic cancer	3.07e-05	0.000204	CcSEcCtD
Diphenhydramine—PTGS1—hematopoietic system—hematologic cancer	3.07e-05	0.0446	CbGeAlD
Diphenhydramine—Decreased appetite—Doxorubicin—hematologic cancer	3.07e-05	0.000203	CcSEcCtD
Diphenhydramine—Headache—Prednisone—hematologic cancer	3.05e-05	0.000202	CcSEcCtD
Diphenhydramine—Fatigue—Doxorubicin—hematologic cancer	3.04e-05	0.000202	CcSEcCtD
Diphenhydramine—Urticaria—Epirubicin—hematologic cancer	3.03e-05	0.000201	CcSEcCtD
Diphenhydramine—Constipation—Doxorubicin—hematologic cancer	3.02e-05	0.0002	CcSEcCtD
Diphenhydramine—Phenytoin—ABCB1—hematologic cancer	2.96e-05	0.0237	CrCbGaD
Diphenhydramine—Asthenia—Methotrexate—hematologic cancer	2.92e-05	0.000194	CcSEcCtD
Diphenhydramine—Feeling abnormal—Doxorubicin—hematologic cancer	2.91e-05	0.000193	CcSEcCtD
Diphenhydramine—Nausea—Prednisone—hematologic cancer	2.89e-05	0.000192	CcSEcCtD
Diphenhydramine—CYP2C19—blood—hematologic cancer	2.87e-05	0.0417	CbGeAlD
Diphenhydramine—Urticaria—Doxorubicin—hematologic cancer	2.8e-05	0.000186	CcSEcCtD
Diphenhydramine—Diarrhoea—Methotrexate—hematologic cancer	2.79e-05	0.000185	CcSEcCtD
Diphenhydramine—Asthenia—Epirubicin—hematologic cancer	2.73e-05	0.000181	CcSEcCtD
Diphenhydramine—Dizziness—Methotrexate—hematologic cancer	2.69e-05	0.000179	CcSEcCtD
Diphenhydramine—Diarrhoea—Epirubicin—hematologic cancer	2.61e-05	0.000173	CcSEcCtD
Diphenhydramine—Vomiting—Methotrexate—hematologic cancer	2.59e-05	0.000172	CcSEcCtD
Diphenhydramine—SLC22A5—blood—hematologic cancer	2.59e-05	0.0376	CbGeAlD
Diphenhydramine—CYP2B6—gonad—hematologic cancer	2.58e-05	0.0375	CbGeAlD
Diphenhydramine—Rash—Methotrexate—hematologic cancer	2.57e-05	0.00017	CcSEcCtD
Diphenhydramine—Dermatitis—Methotrexate—hematologic cancer	2.57e-05	0.00017	CcSEcCtD
Diphenhydramine—Headache—Methotrexate—hematologic cancer	2.55e-05	0.000169	CcSEcCtD
Diphenhydramine—Asthenia—Doxorubicin—hematologic cancer	2.53e-05	0.000168	CcSEcCtD
Diphenhydramine—Dizziness—Epirubicin—hematologic cancer	2.52e-05	0.000167	CcSEcCtD
Diphenhydramine—CYP2D6—hematopoietic system—hematologic cancer	2.52e-05	0.0366	CbGeAlD
Diphenhydramine—Vomiting—Epirubicin—hematologic cancer	2.42e-05	0.000161	CcSEcCtD
Diphenhydramine—Nausea—Methotrexate—hematologic cancer	2.42e-05	0.00016	CcSEcCtD
Diphenhydramine—Diarrhoea—Doxorubicin—hematologic cancer	2.41e-05	0.00016	CcSEcCtD
Diphenhydramine—Rash—Epirubicin—hematologic cancer	2.4e-05	0.000159	CcSEcCtD
Diphenhydramine—Dermatitis—Epirubicin—hematologic cancer	2.4e-05	0.000159	CcSEcCtD
Diphenhydramine—Headache—Epirubicin—hematologic cancer	2.39e-05	0.000158	CcSEcCtD
Diphenhydramine—Trimipramine—ABCB1—hematologic cancer	2.36e-05	0.0189	CrCbGaD
Diphenhydramine—CYP1A2—blood—hematologic cancer	2.34e-05	0.0341	CbGeAlD
Diphenhydramine—Dizziness—Doxorubicin—hematologic cancer	2.33e-05	0.000155	CcSEcCtD
Diphenhydramine—Promethazine—ABCB1—hematologic cancer	2.28e-05	0.0182	CrCbGaD
Diphenhydramine—SLC22A5—lung—hematologic cancer	2.27e-05	0.033	CbGeAlD
Diphenhydramine—Nausea—Epirubicin—hematologic cancer	2.26e-05	0.00015	CcSEcCtD
Diphenhydramine—Tamoxifen—ABCB1—hematologic cancer	2.26e-05	0.0181	CrCbGaD
Diphenhydramine—Doxepin—ABCB1—hematologic cancer	2.25e-05	0.018	CrCbGaD
Diphenhydramine—CYP2B6—blood—hematologic cancer	2.25e-05	0.0327	CbGeAlD
Diphenhydramine—Vomiting—Doxorubicin—hematologic cancer	2.24e-05	0.000149	CcSEcCtD
Diphenhydramine—Methadone—ABCB1—hematologic cancer	2.24e-05	0.0179	CrCbGaD
Diphenhydramine—CYP2C9—blood—hematologic cancer	2.22e-05	0.0324	CbGeAlD
Diphenhydramine—Rash—Doxorubicin—hematologic cancer	2.22e-05	0.000147	CcSEcCtD
Diphenhydramine—Dermatitis—Doxorubicin—hematologic cancer	2.22e-05	0.000147	CcSEcCtD
Diphenhydramine—Headache—Doxorubicin—hematologic cancer	2.21e-05	0.000146	CcSEcCtD
Diphenhydramine—SLC22A5—testis—hematologic cancer	2.14e-05	0.0311	CbGeAlD
Diphenhydramine—Nausea—Doxorubicin—hematologic cancer	2.09e-05	0.000139	CcSEcCtD
Diphenhydramine—CYP1A2—lung—hematologic cancer	2.05e-05	0.0299	CbGeAlD
Diphenhydramine—PTGS1—blood—hematologic cancer	2.03e-05	0.0295	CbGeAlD
Diphenhydramine—CYP2B6—lung—hematologic cancer	1.97e-05	0.0286	CbGeAlD
Diphenhydramine—HRH1—lung—hematologic cancer	1.92e-05	0.028	CbGeAlD
Diphenhydramine—CYP2B6—testis—hematologic cancer	1.86e-05	0.027	CbGeAlD
Diphenhydramine—Amitriptyline—ALB—hematologic cancer	1.83e-05	0.0146	CrCbGaD
Diphenhydramine—HRH1—testis—hematologic cancer	1.81e-05	0.0264	CbGeAlD
Diphenhydramine—PTGS1—lung—hematologic cancer	1.78e-05	0.0259	CbGeAlD
Diphenhydramine—Imipramine—ABCB1—hematologic cancer	1.75e-05	0.014	CrCbGaD
Diphenhydramine—Amitriptyline—ABCB1—hematologic cancer	1.74e-05	0.014	CrCbGaD
Diphenhydramine—PTGS1—testis—hematologic cancer	1.68e-05	0.0244	CbGeAlD
Diphenhydramine—CYP2D6—blood—hematologic cancer	1.67e-05	0.0243	CbGeAlD
Diphenhydramine—SLC22A5—lymph node—hematologic cancer	1.55e-05	0.0226	CbGeAlD
Diphenhydramine—CYP2D6—testis—hematologic cancer	1.38e-05	0.0201	CbGeAlD
Diphenhydramine—HRH1—lymph node—hematologic cancer	1.32e-05	0.0191	CbGeAlD
Diphenhydramine—PTGS1—lymph node—hematologic cancer	1.22e-05	0.0177	CbGeAlD
Diphenhydramine—CHRM2—Signaling Pathways—PDGFRA—hematologic cancer	3.41e-06	7.02e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—JAK1—hematologic cancer	3.4e-06	6.99e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PRKCG—hematologic cancer	3.4e-06	6.99e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.37e-06	6.93e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—NQO1—hematologic cancer	3.35e-06	6.9e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CD44—hematologic cancer	3.35e-06	6.9e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SDC1—hematologic cancer	3.34e-06	6.88e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CREBBP—hematologic cancer	3.34e-06	6.87e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CD44—hematologic cancer	3.32e-06	6.84e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—NQO1—hematologic cancer	3.32e-06	6.84e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—MTHFR—hematologic cancer	3.27e-06	6.73e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CD—hematologic cancer	3.26e-06	6.71e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.25e-06	6.7e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL2RA—hematologic cancer	3.22e-06	6.64e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—ALB—hematologic cancer	3.22e-06	6.62e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CREBBP—hematologic cancer	3.2e-06	6.6e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL2—hematologic cancer	3.2e-06	6.59e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.19e-06	6.57e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TERT—hematologic cancer	3.19e-06	6.56e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYCS—hematologic cancer	3.17e-06	6.53e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL2RA—hematologic cancer	3.17e-06	6.53e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CD—hematologic cancer	3.16e-06	6.51e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.15e-06	6.49e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.15e-06	6.49e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL2—hematologic cancer	3.15e-06	6.48e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYCS—hematologic cancer	3.14e-06	6.48e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TERT—hematologic cancer	3.14e-06	6.46e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.12e-06	6.43e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—ALB—hematologic cancer	3.12e-06	6.43e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PDGFB—hematologic cancer	3.11e-06	6.41e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.08e-06	6.35e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3R1—hematologic cancer	3.08e-06	6.34e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	3.06e-06	6.3e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TSC2—hematologic cancer	3.04e-06	6.26e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTP1—hematologic cancer	3.04e-06	6.26e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CD—hematologic cancer	3.04e-06	6.25e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.01e-06	6.2e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—ALB—hematologic cancer	3e-06	6.17e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TSC2—hematologic cancer	2.99e-06	6.16e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3R1—hematologic cancer	2.99e-06	6.15e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.94e-06	6.06e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FGFR3—hematologic cancer	2.92e-06	6.02e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAPK14—hematologic cancer	2.9e-06	5.96e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	2.88e-06	5.93e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.88e-06	5.93e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3R1—hematologic cancer	2.87e-06	5.91e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	2.85e-06	5.87e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ESR1—hematologic cancer	2.84e-06	5.85e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NQO1—hematologic cancer	2.84e-06	5.85e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CD44—hematologic cancer	2.84e-06	5.85e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CB—hematologic cancer	2.84e-06	5.85e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.81e-06	5.79e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FN1—hematologic cancer	2.81e-06	5.78e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.8e-06	5.76e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ESR1—hematologic cancer	2.8e-06	5.76e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.79e-06	5.75e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.79e-06	5.75e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.78e-06	5.73e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NFKBIA—hematologic cancer	2.77e-06	5.71e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—BAD—hematologic cancer	2.77e-06	5.71e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.77e-06	5.71e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FN1—hematologic cancer	2.76e-06	5.69e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CB—hematologic cancer	2.76e-06	5.68e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NOTCH1—hematologic cancer	2.75e-06	5.65e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CG—hematologic cancer	2.75e-06	5.65e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—BAD—hematologic cancer	2.73e-06	5.62e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	2.73e-06	5.62e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	2.7e-06	5.56e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CD80—hematologic cancer	2.69e-06	5.54e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYCS—hematologic cancer	2.69e-06	5.53e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CG—hematologic cancer	2.69e-06	5.53e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KIT—hematologic cancer	2.69e-06	5.53e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—NRAS—hematologic cancer	2.69e-06	5.53e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.68e-06	5.52e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.67e-06	5.5e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CD80—hematologic cancer	2.65e-06	5.45e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CB—hematologic cancer	2.65e-06	5.45e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.65e-06	5.45e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	2.64e-06	5.44e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KIT—hematologic cancer	2.64e-06	5.44e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	2.64e-06	5.44e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PTPN11—hematologic cancer	2.64e-06	5.43e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.62e-06	5.4e-05	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PIK3CA—hematologic cancer	2.61e-06	5.37e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	2.6e-06	5.35e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—MAPK3—hematologic cancer	2.57e-06	5.3e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.57e-06	5.29e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.57e-06	5.29e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CREB1—hematologic cancer	2.56e-06	5.26e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.55e-06	5.25e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.55e-06	5.25e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CREBBP—hematologic cancer	2.55e-06	5.24e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	2.53e-06	5.21e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—BRAF—hematologic cancer	2.52e-06	5.2e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CREB1—hematologic cancer	2.52e-06	5.18e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCL2—hematologic cancer	2.5e-06	5.15e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL6R—hematologic cancer	2.49e-06	5.13e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CREBBP—hematologic cancer	2.49e-06	5.13e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—BRAF—hematologic cancer	2.48e-06	5.11e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.47e-06	5.08e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCL2—hematologic cancer	2.46e-06	5.07e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTEN—hematologic cancer	2.45e-06	5.05e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL6R—hematologic cancer	2.45e-06	5.05e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	2.45e-06	5.04e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CD—hematologic cancer	2.41e-06	4.97e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.4e-06	4.95e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTEN—hematologic cancer	2.38e-06	4.91e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ALB—hematologic cancer	2.38e-06	4.91e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAP2K1—hematologic cancer	2.38e-06	4.89e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.37e-06	4.88e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CD—hematologic cancer	2.36e-06	4.86e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—EP300—hematologic cancer	2.34e-06	4.82e-05	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.34e-06	4.81e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	2.34e-06	4.81e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	2.32e-06	4.78e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—KRAS—hematologic cancer	2.31e-06	4.76e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	2.3e-06	4.74e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.29e-06	4.72e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTEN—hematologic cancer	2.29e-06	4.71e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3R1—hematologic cancer	2.28e-06	4.69e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	2.27e-06	4.68e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—EP300—hematologic cancer	2.27e-06	4.68e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.27e-06	4.68e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FGF2—hematologic cancer	2.26e-06	4.65e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.25e-06	4.64e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.24e-06	4.62e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3R1—hematologic cancer	2.23e-06	4.59e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FGF2—hematologic cancer	2.22e-06	4.58e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	2.19e-06	4.52e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—EP300—hematologic cancer	2.18e-06	4.49e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.18e-06	4.48e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.18e-06	4.48e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.18e-06	4.48e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—JAK2—hematologic cancer	2.17e-06	4.46e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—JAK2—hematologic cancer	2.13e-06	4.39e-05	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—AKT1—hematologic cancer	2.13e-06	4.39e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PIK3CA—hematologic cancer	2.12e-06	4.37e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MDM2—hematologic cancer	2.11e-06	4.35e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CB—hematologic cancer	2.1e-06	4.33e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	2.09e-06	4.3e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MDM2—hematologic cancer	2.08e-06	4.29e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.07e-06	4.27e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MTOR—hematologic cancer	2.06e-06	4.24e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CB—hematologic cancer	2.06e-06	4.24e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MTOR—hematologic cancer	2.02e-06	4.17e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	2.02e-06	4.17e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.98e-06	4.09e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—HRAS—hematologic cancer	1.96e-06	4.05e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	1.93e-06	3.98e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CDKN1B—hematologic cancer	1.93e-06	3.98e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.92e-06	3.96e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.92e-06	3.96e-05	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—AKT1—hematologic cancer	1.91e-06	3.93e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.91e-06	3.93e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	1.9e-06	3.91e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CASP3—hematologic cancer	1.89e-06	3.9e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.89e-06	3.89e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL2—hematologic cancer	1.89e-06	3.89e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL6—hematologic cancer	1.88e-06	3.87e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	1.88e-06	3.87e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CASP3—hematologic cancer	1.86e-06	3.83e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL2—hematologic cancer	1.86e-06	3.83e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL6—hematologic cancer	1.85e-06	3.81e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCND1—hematologic cancer	1.84e-06	3.79e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—JUN—hematologic cancer	1.84e-06	3.79e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.82e-06	3.76e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTEN—hematologic cancer	1.82e-06	3.74e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCND1—hematologic cancer	1.81e-06	3.73e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—JUN—hematologic cancer	1.81e-06	3.72e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ALB—hematologic cancer	1.8e-06	3.71e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	1.78e-06	3.67e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PTEN—hematologic cancer	1.78e-06	3.66e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.77e-06	3.64e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.75e-06	3.61e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	1.75e-06	3.61e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PTEN—hematologic cancer	1.75e-06	3.6e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAPK8—hematologic cancer	1.74e-06	3.58e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—AKT1—hematologic cancer	1.73e-06	3.57e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—EP300—hematologic cancer	1.73e-06	3.57e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CA—hematologic cancer	1.73e-06	3.56e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.72e-06	3.55e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	1.71e-06	3.52e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	1.71e-06	3.51e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EP300—hematologic cancer	1.7e-06	3.49e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.7e-06	3.49e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CA—hematologic cancer	1.68e-06	3.46e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.68e-06	3.45e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EP300—hematologic cancer	1.67e-06	3.44e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.66e-06	3.42e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ALB—hematologic cancer	1.66e-06	3.41e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SRC—hematologic cancer	1.65e-06	3.4e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ALB—hematologic cancer	1.64e-06	3.38e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SRC—hematologic cancer	1.62e-06	3.34e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.62e-06	3.33e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CA—hematologic cancer	1.61e-06	3.32e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	1.61e-06	3.31e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—STAT3—hematologic cancer	1.59e-06	3.27e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.59e-06	3.27e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NRAS—hematologic cancer	1.59e-06	3.27e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.58e-06	3.26e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	1.58e-06	3.25e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.57e-06	3.23e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—STAT3—hematologic cancer	1.56e-06	3.22e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NRAS—hematologic cancer	1.56e-06	3.21e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	1.52e-06	3.13e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.5e-06	3.09e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	1.49e-06	3.08e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MYC—hematologic cancer	1.48e-06	3.04e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	1.47e-06	3.04e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.46e-06	3.01e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MYC—hematologic cancer	1.45e-06	2.99e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	1.45e-06	2.99e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.45e-06	2.98e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.42e-06	2.93e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—AKT1—hematologic cancer	1.41e-06	2.91e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ALB—hematologic cancer	1.4e-06	2.89e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTEN—hematologic cancer	1.37e-06	2.83e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—AKT1—hematologic cancer	1.37e-06	2.83e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KRAS—hematologic cancer	1.37e-06	2.81e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KRAS—hematologic cancer	1.34e-06	2.77e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.34e-06	2.76e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—AKT1—hematologic cancer	1.32e-06	2.71e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—EP300—hematologic cancer	1.31e-06	2.7e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.28e-06	2.64e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.26e-06	2.6e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	1.25e-06	2.58e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTEN—hematologic cancer	1.25e-06	2.58e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.24e-06	2.55e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	1.23e-06	2.54e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TP53—hematologic cancer	1.21e-06	2.5e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—EP300—hematologic cancer	1.2e-06	2.48e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—EP300—hematologic cancer	1.19e-06	2.46e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TP53—hematologic cancer	1.19e-06	2.46e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HRAS—hematologic cancer	1.16e-06	2.39e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HRAS—hematologic cancer	1.14e-06	2.35e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL6—hematologic cancer	1.11e-06	2.29e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL6—hematologic cancer	1.09e-06	2.25e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTEN—hematologic cancer	1.07e-06	2.2e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—AKT1—hematologic cancer	1.05e-06	2.16e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKT1—hematologic cancer	1.02e-06	2.11e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—EP300—hematologic cancer	1.02e-06	2.1e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKT1—hematologic cancer	1.01e-06	2.08e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	9.69e-07	2e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	8.91e-07	1.84e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	8.84e-07	1.82e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AKT1—hematologic cancer	7.92e-07	1.63e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	7.55e-07	1.55e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AKT1—hematologic cancer	7.28e-07	1.5e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AKT1—hematologic cancer	7.22e-07	1.49e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AKT1—hematologic cancer	6.17e-07	1.27e-05	CbGpPWpGaD
